Pan-TRK Tumour Biomarker Test, NTRK

Solid Tumour Biomarker Testing, NTRK, NTRK1, NTRK2, NTRK3
Anatomical Pathology
Surgical Pathology

Other Information
Screening by IHC, followed by confirmatory fusion testing if a variant is identified.
NTRK testing is incorporated into existing panel testing at diagnosis for the following:
• Non-Small Cell Lung Cancer
• Thyroid cancer
Testing for adult patients with advanced/metastatic solid tumour cancers where NTRK directed therapy is being considered (where surgical resection is likely to result in severe morbidity, and have no satisfactory treatment options) Biomarkers: NTRK1, NTRK2, NTRK3 (Pan-TRK)
Formalin fixed paraffin embedded block or tissue sections cut at 4 microns mounted on "Superfrost Plus" charged slides.
Dako Omnis
Monday to Friday; 8 am to 5 pm
Please refer directly to the Pathology Report
Tel: (416) 586-4800 extension 4457
Fax: (416) 586-8628
Email: PLMconsults@sinaihealth.ca